These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 33593773)

  • 1. Protocol for a systematic review and meta-analysis of the placebo response in treatment-resistant depression: comparison of multiple treatment modalities.
    Jones BDM; Weissman CR; Razza LB; Husain MI; Brunoni AR; Daskalakis ZJ
    BMJ Open; 2021 Feb; 11(2):e041349. PubMed ID: 33593773
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy and acceptability of adjunctive psychological and pharmacological interventions for treatment-resistant depression: protocol for a systematic review and network meta-analysis.
    Husain MI; Strawbridge R; Carter B; Jones BDM; Young A; Carvalho AF
    BMJ Open; 2019 May; 9(5):e028538. PubMed ID: 31092667
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy and acceptability of next step treatment strategies in adults with treatment-resistant major depressive disorder: protocol for systematic review and network meta-analysis.
    Muit JJ; van Eijndhoven PFP; Cipriani A; Dalhuisen I; van Bronswijk S; Furukawa TA; Ruhe HG
    BMJ Open; 2022 Apr; 12(4):e056777. PubMed ID: 35437250
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Magnitude of the Placebo Response Across Treatment Modalities Used for Treatment-Resistant Depression in Adults: A Systematic Review and Meta-analysis.
    Jones BDM; Razza LB; Weissman CR; Karbi J; Vine T; Mulsant LS; Brunoni AR; Husain MI; Mulsant BH; Blumberger DM; Daskalakis ZJ
    JAMA Netw Open; 2021 Sep; 4(9):e2125531. PubMed ID: 34559231
    [TBL] [Abstract][Full Text] [Related]  

  • 5. PAX-D: study protocol for a randomised placebo-controlled trial evaluating the efficacy and mechanism of pramipexole as add-on treatment for people with treatment resistant depression.
    Au-Yeung SK; Griffiths J; Roberts S; Edwards C; Yu LM; Bogacz R; Rendell J; Attenburrow MJ; Watson S; Chan F; Cipriani A; Cleare A; Harmer CJ; Kessler D; Evans J; Lewis G; Singh I; Simon J; Harrison PJ; Cowen P; Shanyinde M; Geddes J; Browning M
    Evid Based Ment Health; 2022 May; 25(2):77-83. PubMed ID: 34810175
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparative efficacy and acceptability of 21 antidepressant drugs for the acute treatment of adults with major depressive disorder: a systematic review and network meta-analysis.
    Cipriani A; Furukawa TA; Salanti G; Chaimani A; Atkinson LZ; Ogawa Y; Leucht S; Ruhe HG; Turner EH; Higgins JPT; Egger M; Takeshima N; Hayasaka Y; Imai H; Shinohara K; Tajika A; Ioannidis JPA; Geddes JR
    Lancet; 2018 Apr; 391(10128):1357-1366. PubMed ID: 29477251
    [TBL] [Abstract][Full Text] [Related]  

  • 7. What is the meaning of treatment resistant/refractory major depression (TRD)? A systematic review of current randomized trials.
    Berlim MT; Turecki G
    Eur Neuropsychopharmacol; 2007 Nov; 17(11):696-707. PubMed ID: 17521891
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy, quality of life, and acceptability outcomes of atypical antipsychotic augmentation treatment for treatment-resistant depression: protocol for a systematic review and network meta-analysis.
    Liu Y; Zhou X; Qin B; Del Giovane C; Zhang Y; Xie P
    Syst Rev; 2014 Nov; 3():133. PubMed ID: 25373601
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy of infliximab in treatment-resistant depression: A systematic review and meta-analysis.
    Bavaresco DV; Uggioni MLR; Ferraz SD; Marques RMM; Simon CS; Dagostin VS; Grande AJ; da Rosa MI
    Pharmacol Biochem Behav; 2020 Jan; 188():172838. PubMed ID: 31837338
    [TBL] [Abstract][Full Text] [Related]  

  • 10. N-acetylcysteine as add-on to antidepressant medication in therapy refractory major depressive disorder patients with increased inflammatory activity: study protocol of a double-blind randomized placebo-controlled trial.
    Yang C; Bosker FJ; Li J; Schoevers RA
    BMC Psychiatry; 2018 Sep; 18(1):279. PubMed ID: 30176835
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparative efficacy and tolerability of pharmacological and somatic interventions in adult patients with treatment-resistant depression: a systematic review and network meta-analysis.
    Papadimitropoulou K; Vossen C; Karabis A; Donatti C; Kubitz N
    Curr Med Res Opin; 2017 Apr; 33(4):701-711. PubMed ID: 28035869
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of Minocycline as an Adjunct Neuroinflammatory Modulator in Treatment-Resistant Depression: A Systematic Review of Randomized Controlled Trials.
    Al Jumaili W; Vora D; Trivedi C; Jain S
    Prim Care Companion CNS Disord; 2023 Sep; 25(5):. PubMed ID: 37713730
    [No Abstract]   [Full Text] [Related]  

  • 13. Dialectical Behavior Therapy as an intervention for Treatment Resistant Depression in adults: A protocol for systematic review and meta-analysis.
    Junkes L; Gherman BR; Appolinario JC; Nardi AE
    PLoS One; 2024; 19(5):e0303967. PubMed ID: 38776336
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Augmentation therapies for treatment-resistant depression: systematic review and meta-analysis.
    Strawbridge R; Carter B; Marwood L; Bandelow B; Tsapekos D; Nikolova VL; Taylor R; Mantingh T; de Angel V; Patrick F; Cleare AJ; Young AH
    Br J Psychiatry; 2019 Jan; 214(1):42-51. PubMed ID: 30457075
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparative efficacy and acceptability of interventions for major depression in older persons: protocol for Bayesian network meta-analysis.
    Liew TM; Lee CS
    BMJ Open; 2018 Jan; 8(1):e019819. PubMed ID: 29358451
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A systematic review and meta-analysis on placebo response to repetitive transcranial magnetic stimulation for depression trials.
    Razza LB; Moffa AH; Moreno ML; Carvalho AF; Padberg F; Fregni F; Brunoni AR
    Prog Neuropsychopharmacol Biol Psychiatry; 2018 Feb; 81():105-113. PubMed ID: 29111404
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Use of nitrous oxide in the treatment of major depressive disorder and treatment-resistant major depressive disorder: A systematic review and meta-analysis nitrous oxide in depressive disorders.
    Rech P; Custodio RM; Rodrigues Uggioni ML; Silveira Prestes G; Marçal F; Silveira VP; Dagostin VS; Colonetti T; Rosa MI
    Prog Neuropsychopharmacol Biol Psychiatry; 2024 Feb; 129():110869. PubMed ID: 37813146
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Network meta-analysis of randomised trials of pharmacological, psychotherapeutic, exercise and collaborative care interventions for depressive symptoms in patients with coronary artery disease: hybrid systematic review of systematic reviews protocol.
    Doyle F; Freedland K; Carney R; de Jonge P; Dickens C; Pedersen S; Sorensen J; Dempster M
    Syst Rev; 2019 Mar; 8(1):71. PubMed ID: 30878039
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Amitriptyline versus placebo for major depressive disorder.
    Leucht C; Huhn M; Leucht S
    Cochrane Database Syst Rev; 2012 Dec; 12():CD009138. PubMed ID: 23235671
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Relative effectiveness of augmentation treatments for treatment-resistant depression: a systematic review and network meta-analysis.
    Carter B; Strawbridge R; Husain MI; Jones BDM; Short R; Cleare AJ; Tsapekos D; Patrick F; Marwood L; Taylor RW; Mantingh T; de Angel V; Nikolova VL; Carvalho AF; Young AH
    Int Rev Psychiatry; 2020; 32(5-6):477-490. PubMed ID: 32498577
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.